ImmuCell Corporation (ICCC)
NASDAQ · Healthcare
ImmuCell Corporation EBITDA 2017–2025
ImmuCell Corporation annual/quarterly ebitda history and growth rate from 2024 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- ImmuCell Corporation ebitda for the quarter ending March 31, 2026 was 2.5 M, a 38.59% increase year-over-year.
- ImmuCell Corporation ebitda for the twelve months ending March 31, 2026 was 5.1 M.
- ImmuCell Corporation annual ebitda for 2025 was 4.4 M, a 306.84% increase from 2024.
- ImmuCell Corporation annual ebitda for 2024 was 1.1 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
ImmuCell Corporation EBITDA — FAQ
ImmuCell Corporation (ICCC) ebitda over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ICCC's ebitda history?
The chart and table above show ImmuCell Corporation's ebitda by year and by quarter, including the growth rate.